Tue. 2 Apr 2024, 8:13am ET
Benzinga
Earnings, Earnings Beats, News
Cardiol Therapeutics (NASDAQ:CRDL) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.12) by 25 percent. This is a 12.5 percent decrease over losses of $(0.08) per share from the same period last year.